Onychomycosis among women who use nail cosmetics is the subject of a new study published in Nature, conducted at the dermatology clinic of Mbarara Regional Referral Hospital in southwestern Uganda. The paper reports prevalence, etiology and associated factors for the fungal nail infection in this specific cosmetic-using cohort — a group dermatologists see constantly, yet one that hardly ever gets its own epidemiological profile in East African settings.

The study setting matters. Mbarara Regional Referral Hospital serves a mixed urban and rural catchment in Uganda, and its dermatology clinic is where the researchers recruited women presenting with nail complaints who reported cosmetic nail use. That framing — cosmetic users, not the general population — is the useful part. It lets the authors separate behavior-linked risk from baseline disease burden.

Why does a single-center prevalence figure matter?

Because onychomycosis is notoriously under-characterized in sub-Saharan Africa. Global estimates exist, but they lean heavily on data from temperate, high-income populations. When a peer-reviewed journal of Nature's caliber publishes Uganda-specific prevalence and etiology data, it gives clinicians in the region a benchmark that actually resembles their patients.

For practitioners, three things in this paper are worth the read:

• Prevalence in a defined cohort — how common onychomycosis is among women using nail cosmetics at this clinic
• Etiology — which fungal organisms are driving the infections, which directly shapes antifungal choice
• Associated factors — the behavioral and clinical variables that travel with infection in this population

What does this change for clinicians?

The practical question any dermatologist will ask: does cosmetic nail use itself raise infection risk, or is it a marker for something else? The study's associated-factors analysis speaks to that, and the answer shapes how you counsel patients who frequent nail salons.

Nail cosmetics — polish, acrylics, gel systems, artificial nails — have long been suspected of promoting fungal disease through occlusion, trauma to the nail plate, and contaminated application tools. Salon hygiene practices vary widely, and in many markets they are essentially unregulated. A clinic-based study from Uganda adds region-specific evidence to a literature that has relied mostly on case reports and small series.

Etiology matters as much as prevalence. Onychomycosis can be caused by dermatophytes, yeasts or non-dermophyte molds, and the mix varies by geography and climate. If the Mbarara data show a different organism distribution than textbooks assume — and tropical settings often do — then empirical antifungal choices may need adjusting. Terbinafine works brilliantly for dermatophytes, less so for candida and molds.

Counseling implications

For dermatologists who see cosmetic nail users, the study reinforces a counseling framework:

• Ask directly about cosmetic nail use, including salon visits and home application
• Examine for early nail-plate changes before they advance
• Confirm diagnosis with mycology where available, rather than treating empirically
• Discuss hygiene at salons — tool sterilization matters as much as product choice

The study also quietly makes a case for mycology capacity. In many referral hospitals in the region, potassium hydroxide microscopy and culture are not always accessible, which pushes clinicians toward empirical treatment. Better local etiology data like this helps make empirical choices smarter even when confirmatory testing is out of reach.

The bigger picture

The global nail-care market keeps growing, and women in low- and middle-income countries are increasingly part of it. That trend will keep pushing cosmetic-associated nail disease into dermatology clinics. Epidemiological groundwork from settings like Mbarara gives the field a factual base it has lacked.

The full paper, with its prevalence figures, organism breakdown and associated-factor analysis, is available through Nature. Expect follow-up work — multi-center and ideally longitudinal — to build on this baseline, and to test whether salon-hygiene interventions can cut infection rates in cosmetic nail users.